Intraoperative Versus CT Guided Celiac Plexus Neurolysis in Unresectable Pancreatic Cancer
NCT ID: NCT03770247
Last Updated: 2019-12-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
76 participants
INTERVENTIONAL
2018-09-01
2019-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
intraoperative group (IOCPN group)
Intraoperative celiac plexus neurolysis Before closure of the abdomen the surgeon will expose the aorta at the level of the celiac trunk.With the stomach retracted inferiorly, the index and second finger of the surgeon's left hand straddle the aorta with the index finger placed on the splenic artery and the second finger on the common hepatic artery. we will use of a 20- gauge spinal needle (in contrast to the usual short intravenous needle) allows better visualization and access to this area, especially in deep patients, while a 10 ml syringe permits the surgeon to control the injection with the right hand alone.(10) Twenty ml of 90 % alcohol, five ml lidocaine 2%, five mg dexamethasone will be injected in each side of the aorta after aspiration to exclude intravascular or subarachnoid injection.
Intraoperative celiac plexus neurolysis
neurolysis of celiac plexus by intraoperative techniques
CT group (CTCPN group)
CT guided celiac plexus neurolysis After one week of the operation and the patient completely awake, the patient will be transferred to CT lab. The procedure will be done after attachment of basic monitors and transfusion of 500 ml saline in 20 G cannula before starting the procedure and the patient will be given 5 mg midazolam as a sedation. The procedure will be done by anesthetist and radiologist who had a good experience in celiac plexus neurolysis. In our study we will use the classic posterior bilateral approach. The patient will be in the prone position. After sterilization of the back by chlorohixidine 10 % , subcutaneous injection of 5 ml lidocaine as a local anaesthesia until a wheel will be formed then the procedure will be done. We will use 20 G Chiba needle under guidance of CT. Twenty ml of 95% alcohol , five ml lidocaine 2 % and five mg dexamethasone in each side of the aorta after aspiaration to exclude intravascular injection and subarachnoid injection
CT guided celiac plexus neurolysis
Neurolysis of celiac plexus percutaneously by CT guidance
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intraoperative celiac plexus neurolysis
neurolysis of celiac plexus by intraoperative techniques
CT guided celiac plexus neurolysis
Neurolysis of celiac plexus percutaneously by CT guidance
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients proven histololgically to be unresectable
* patients undergoing either biopsy or bypass surgery
Exclusion Criteria
* Patient with coagulopathy.
* patient with aortic aneurysm.
* patient with any disease contraindicating any sympathetic blockade as advanced cardiac disease .
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mansoura University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tarek M. Shams, MD
Role: STUDY_DIRECTOR
: Professor of Anesthesia and Surgical Intensive Care
Mahmoud M. Elsedeiq, MSc
Role: PRINCIPAL_INVESTIGATOR
assistan lecturer of Anesthesia and Surgical Intensive Care
Mohamed A. Ghanim, MD
Role: STUDY_CHAIR
Assistant Professor of Anesthesia and Surgical Intensive Care
Ibrahim I. Abd El-basir, MD
Role: STUDY_CHAIR
Lecturer of Anesthesia and Surgical Intensive Care
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mansoura university , gastrointestinal surgery center
Al Mansurah, Dakahlia Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MD ∕ 17.08.53
Identifier Type: -
Identifier Source: org_study_id